HOPE-TMS-OF-NY-SCIENTIFIC-PUBLICATIONS-PRESENTATIONS
       Hope TMS and Neuropsychiatric Center 
646 558 5299
Elvin Ruiz M.D.
Home
About Hope TMS
Neuropsychiatry
About TMS
For Patients
HealthcareProviders
Insurance


57 West 57th Street       Suite 808       New York, New York       10019
57 West 57th Street      Suite 808      New York, New York      10019
SCIENTIFIC PUBLICATIONS  & CLINICAL PRESENTATIONS


O’Reardon, J. P., H. B. Solvason, et al. (2007). “Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial.” Biol Psychiatry 62(11): 1208-1216. http://www.ncbi.nlm.nih.gov/pubmed/17573044

Lisanby, S. H., M. M. Husain, et al. (2009). “Daily Left Prefrontal Repetitive Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: Clinical Predictors of Outcome in a Multisite, Randomized Controlled Clinical Trial.” Neuropsychopharmacology 34(2): 522-534. http://www.ncbi.nlm.nih.gov/pubmed/18704101

Janicak, P., J. P. O’Reardon, et al. (2008). “Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder: A Comprehensive Summary of Safety Experience from Acute Exposure, Extended Exposure, and During Reintroduction Treatment.” Journal of Clinical Psychiatry 69(2): 222 – 232. http://www.ncbi.nlm.nih.gov/pubmed/18232722

Avery, D. H., K. E. Isenberg, et al. (2008). “Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder: Clinical Response in an Open-Label Extension Trial.” J Clin Psychiatry 69(3): 441-451. 
http://www.ncbi.nlm.nih.gov/pubmed/18294022

Demitrack, M. A. and M. Thase (2009). “Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data.” Psychopharmacology Bulletin 42(2): 5 – 38. http://www.ncbi.nlm.nih.gov/pubmed/19629020

Simpson, K. N., M. J. Welch, et al. (2010). “Cost-Effectiveness of Transcranial Magnetic Stimulation in the Treatment of Major Depression: a Health Economics Analysis.” Adv Ther 26(7): 737. http://www.ncbi.nlm.nih.gov/pubmed/19330495

Janicak, P. G., Z. Nahas, et al. (2010). “Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month,multisite, open-label study.” Brain Stimulation 3(4): 187-199. http://www.ncbi.nlm.nih.gov/pubmed/20965447

Additionally, a National Institute of Mental Health (NIMH) sponsored clinical program using the NeuroStar® system was conducted at four medical centers.

George, M. S., S. H. Lisanby, et al. (2010). “Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder A Sham-Controlled Randomized Trial.” Arch Gen Psychiatry. 67(5): 507 – 516. http://www.ncbi.nlm.nih.gov/pubmed/20439832



The above is only a sampling of the clinical research and literature available for review.  If you are looking for areas of interest outside of those listed above, or have any questions about TMS, its applications, safety, efficacy, or anything at all, please feel free to contact me directly.
Elvin Ruiz M.D.